A calcium fluoride scale inhibitor, its preparation method and application

By compounding aminotrimethylene phosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid and polyamide-amine dendritic macromolecules, the calcium fluoride scale inhibitor formed can effectively inhibit calcium fluoride scaling under high calcium and high fluoride conditions, solving the problem of insufficient scale inhibition effect in the existing technology and achieving efficient scale control.

CN123105871APending Publication Date: 2026-11-17GUANGDONG GDH WATER +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611409795.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-11
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing calcium fluoride scale inhibitors are not effective in inhibiting scale formation in high-calcium and high-fluoride water bodies. Furthermore, as the concentration of fluoride ions increases, the dosage of scale inhibitor needs to be increased, making it difficult to effectively suppress calcium fluoride scaling.

Method used

A calcium fluoride scale inhibitor is formed by combining aminotrimethylene phosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, and polyamide-amine dendritic macromolecules, which inhibit the nucleation and growth of calcium fluoride crystals through complexation, adsorption, and multifunctional group interactions.

Benefits of technology

With a low dosage of scale inhibitor, significant inhibition of calcium fluoride scaling is achieved, with a scale inhibition rate of over 90%. It is suitable for the deep treatment of high-calcium and high-fluoride industrial wastewater and the reuse of reclaimed water.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
Patent Text Reader

Abstract

This invention relates to a calcium fluoride scale inhibitor, its preparation method, and its application. The invention addresses the shortcomings of existing calcium fluoride scale inhibitors in high-calcium, high-fluoride water bodies, and the need to increase the dosage of the scale inhibitor as the fluoride ion concentration rises. The scale inhibitor of this invention comprises 20%–30% aminotrimethylenephosphonic acid (ATMP), 5%–15% 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA), 2%–8% polyamide-amine dendritic macromolecules (PAMAM), and the balance being water. The scale inhibitor is prepared by mixing and stirring the components in a specific ratio; the preparation process is simple and requires no complex reaction procedures. ATMP, PBTCA, and PAMAM exert a synergistic inhibitory effect on the calcium fluoride scaling process through calcium ion complexation, crystal surface adsorption, and interference with the nucleation and growth of calcium fluoride crystals. The scale inhibitor obtained by this invention is suitable for controlling calcium fluoride scaling in calcium- and fluoride-containing industrial wastewater and reverse osmosis membrane systems. This invention belongs to the field of water treatment technology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a scale inhibitor, its preparation method, and its application, belonging to the field of water treatment technology. Background Technology

[0002] With the development of industrial production, the amount of fluoride-containing industrial wastewater is constantly increasing. Especially in the production processes of electronics, semiconductors, photovoltaics, and related chemical industries, industrial wastewater containing high concentrations of fluoride ions is generated. To achieve compliant discharge and resource reuse of industrial wastewater, defluorination treatment is usually required, followed by further deep treatment and reclaimed water reuse through membrane separation technologies such as reverse osmosis. In the treatment of fluoride-containing industrial wastewater, calcium salt agents such as calcium hydroxide are often used to remove fluoride ions through chemical precipitation. After defluorination treatment, a certain concentration of fluoride ions may still remain in the water, and the calcium ion concentration in the water will also increase accordingly due to the addition of calcium salt agents. When the treated water further enters the reverse osmosis membrane treatment system, the concentrations of calcium and fluoride ions in the water continuously increase under the concentration effect, easily reaching a supersaturated state of calcium fluoride. This leads to calcium fluoride nucleation, crystal growth, and crystal deposition, forming a calcium fluoride scale layer on the membrane surface.

[0003] Calcium fluoride has low solubility, and the resulting crystal scale layer is relatively dense and difficult to remove under conventional water treatment conditions. Continuous deposition of calcium fluoride on the reverse osmosis membrane surface can lead to decreased membrane flux, increased operating pressure, and reduced system permeate capacity; in severe cases, it may even affect the normal operation and lifespan of membrane elements. Therefore, adding a suitable calcium fluoride scale inhibitor before fluoride-containing water enters the membrane treatment system is an important measure to reduce the risk of membrane scaling and ensure the long-term stable operation of the membrane system. Existing scale inhibitors mainly include organophosphonates, polycarboxylic acids, and various compound scale inhibitors. Organophosphonate scale inhibitors have good metal ion complexing ability and crystal growth inhibition ability, but the mechanism of action of single-component scale inhibitors is relatively limited. When high concentrations of calcium and fluoride ions are present in the water, a single scale inhibitor may be unable to maintain high calcium fluoride scale inhibition performance. Furthermore, with the increasing requirements for the treatment of fluoride-containing industrial wastewater and the reuse of reclaimed water, higher demands are placed on the scale inhibition performance of scale inhibitors under high calcium and high fluoride conditions and their performance at low dosages.

[0004] Therefore, it is necessary to develop a compound calcium fluoride scale inhibitor for calcium- and fluoride-containing water bodies. Through the synergistic effect between different types of scale inhibitory components, the ability to inhibit the nucleation and crystal growth process of calcium fluoride can be improved, thereby reducing the risk of calcium fluoride scaling during fluoride water treatment and membrane separation. Summary of the Invention

[0005] This invention addresses the problem that existing calcium fluoride scale inhibitors are insufficient in inhibiting scale in high-calcium and high-fluoride water bodies, and that the dosage of scale inhibitor needs to be increased as the fluoride ion concentration rises. Therefore, this invention proposes a calcium fluoride scale inhibitor, its preparation method, and its application.

[0006] The technical solution adopted by the present invention to solve the above problems is as follows: The calcium fluoride scale inhibitor of the present invention comprises aminotrimethylenephosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, polyamide-amine dendritic macromolecule and aqueous solution, wherein the mass percentage of each component is: aminotrimethylenephosphonic acid 20% to 30%, 2-phosphonobutane-1,2,4-tricarboxylic acid 5% to 15%, and polyamide-amine dendritic macromolecule 2% to 8%.

[0007] Furthermore, aminotrimethylenephosphonic acid is used to inhibit the formation of calcium fluoride crystals by calcium ions and fluoride ions through complexation and adsorption, and to inhibit the nucleation and growth of calcium fluoride crystals.

[0008] Furthermore, 2-phosphonobutane-1,2,4-tricarboxylic acid is used to reduce the formation and deposition of calcium fluoride crystals by complexing with calcium ions in water and adsorbing onto the surface of calcium fluoride crystals.

[0009] Furthermore, polyamide-amine dendritic macromolecules can interact with calcium ions and the surface of calcium fluoride crystals in water through their multifunctional structure, thereby inhibiting the nucleation, growth, and aggregation of calcium fluoride crystals.

[0010] Furthermore, the aqueous solution is deionized water.

[0011] The preparation method of the calcium fluoride scale inhibitor of the present invention is achieved through the following steps: Step 1: Weigh out aminotrimethylenephosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, polyamide-amine dendritic macromolecules and aqueous solution according to the predetermined mass percentage; Step 2: Add water to the reaction vessel, and under stirring conditions, add aminotrimethylene phosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid and polyamide-amine dendritic macromolecules in sequence. Step 3: Continue stirring until all components are fully mixed and homogeneous to obtain the calcium fluoride scale inhibitor.

[0012] Furthermore, the mixing process in step 3 is carried out at room temperature, and the mixture is stirred until the solution is uniformly transparent or uniformly dispersed.

[0013] The calcium fluoride scale inhibitor described in this invention is applied to calcium- and fluoride-containing water treatment to inhibit the formation, nucleation, growth, and deposition of calcium fluoride scale during the water treatment process.

[0014] The beneficial effects of this invention are: 1. This invention uses three different types of scale inhibitors, ATMP, PBTCA and PAMAM, to form a compound. Each component can inhibit calcium fluoride scaling through calcium ion complexation, crystal surface adsorption and crystal growth interference, and has the characteristics of multi-mechanism synergistic scale inhibition.

[0015] 2. This invention is designed for water bodies containing calcium and fluoride. Under conditions of calcium ion concentration of 300 mg / L and fluoride ion concentration of 20 mg / L, the scale inhibition rate reaches over 90% when the scale inhibitor dosage is 10 ppm; when the fluoride ion concentration increases to 40 mg / L, the scale inhibition rate reaches over 85% when the scale inhibitor dosage is 15 ppm; and when the fluoride ion concentration further increases to 80 mg / L, the scale inhibition rate reaches over 70% when the scale inhibitor dosage is 20 ppm.

[0016] 3. This invention, through the compounding of ATMP, PBTCA and PAMAM, can significantly inhibit the scaling process of calcium fluoride at a relatively low dosage of scale inhibitor, and can be used for scale control in the deep treatment of high-calcium and high-fluoride industrial wastewater and the reuse of reclaimed water.

[0017] 4. This invention uses mature industrial raw materials and can be prepared by physical compounding at room temperature. The preparation process does not require complex reaction equipment, the process is simple, and it is easy to scale up production and apply on site. Attached Figure Description

[0018] Figure 1 This is a schematic diagram of the finished calcium fluoride scale inhibitor prepared in Example 1; Figure 2 The bar chart shows the static scale inhibition rate of the examples and comparative examples. Detailed Implementation

[0019] Specific Implementation Method 1: The calcium fluoride scale inhibitor described in this implementation method is composed of aminotrimethylene phosphonic acid (ATMP), 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA), polyamide-amine dendritic macromolecule (PAMAM), and water.

[0020] The components, by mass percentage, include: aminotrimethylenephosphonic acid (ATMP): 20%–30%; 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA): 5%–15%; polyamide-amine dendritic macromolecule (PAMAM): 2%–8%; water: balance; the sum of the mass percentages of the above components is 100%.

[0021] In some embodiments, the mass percentages of each component are as follows: aminotrimethylenephosphonic acid (ATMP): 22%–28%; 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA): 8%–12%; polyamide-amine dendritic macromolecule (PAMAM): 3%–7%; water: 53%–67%.

[0022] In some embodiments, the mass percentages of the components are as follows: aminotrimethylenephosphonic acid (ATMP): 25%; 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA): 10%; polyamide-amine dendritic macromolecule (PAMAM): 5%; water: 60%.

[0023] Specific Implementation Method Two: The preparation method of the calcium fluoride scale inhibitor described in this implementation method is achieved through the following steps: Step 1: Weigh out aminotrimethylenephosphonic acid (ATMP), 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA), polyamide-amine dendritic macromolecule (PAMAM), and water according to the predetermined mass percentages. Step 2: Add the predetermined amount of water to the mixing container and turn on the mixer; Step 3: Under stirring conditions, add aminotrimethylenephosphonic acid (ATMP), 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTCA), and polyamide-amine dendritic macromolecule (PAMAM) in sequence. Step 4: Continue stirring to ensure that all components are fully mixed and homogeneous, thus obtaining the calcium fluoride scale inhibitor.

[0024] The entire preparation process is carried out under normal temperature and pressure conditions; the stirring time is 30 to 60 minutes until all components are fully mixed and form a uniform and stable liquid compound scale inhibitor.

[0025] The functions of each component in this embodiment are as follows: Aminotrimethylenephosphonic acid (ATMP) has a strong metal ion complexing ability. It can complex with calcium ions in water, reducing the effective concentration of free calcium ions. At the same time, it interferes with the formation process of calcium fluoride crystals through adsorption, thereby inhibiting the nucleation and growth of calcium fluoride crystals.

[0026] 2-Phosphonobutane-1,2,4-tricarboxylic acid (PBTCA) possesses both phosphonic acid and carboxylic acid groups, which can complex with calcium ions and act on the surface of calcium fluoride crystals, interfering with the normal crystal growth process. When PBTCA is combined with ATMP, it can synergistically inhibit the formation of calcium ions and calcium fluoride crystals through different sites of action.

[0027] Polyamide-amine dendritic macromolecules (PAMAMs) have a highly branched three-dimensional structure and a large number of end functional groups. They can interact with calcium ions in water and calcium fluoride microcrystals during the formation process, affecting crystal nucleation, crystal growth and microcrystal aggregation, thereby further improving the ability of the compound system to inhibit the calcium fluoride scaling process.

[0028] Water is used as a solvent to dissolve and disperse ATMP, PBTCA, and PAMAM, so that the components form a homogeneous and stable liquid compound system.

[0029] Example Example 1 In this embodiment, a calcium fluoride scale inhibitor is prepared according to the following mass percentages: ATMP: 25%; PBTCA: 10%; PAMAM: 5%; Deionized water: 60%.

[0030] Preparation method: Weigh each component according to the above mass ratio. Weigh 60g of deionized water and add it to the stirring container. Turn on the stirring and add 25g of ATMP, 10g of PBTCA and 5g of PAMAM in sequence. Stir continuously at room temperature for 30-60 minutes to ensure that the components are fully mixed and homogeneous, and obtain the finished calcium fluoride scale inhibitor.

[0031] Example 2 This embodiment is used to investigate the scale inhibition performance of the calcium fluoride scale inhibitor obtained in Example 1 under different fluoride ion concentrations.

[0032] A water sample was prepared to achieve a calcium ion concentration of 300 mg / L and a fluoride ion concentration of 20 mg / L. The calcium fluoride scale inhibitor obtained in Example 1 was added to a dosage of 10 ppm. Scale inhibition performance testing showed that the obtained calcium fluoride achieved a scale inhibition rate of over 90%.

[0033] Example 3 Prepare a water sample with a calcium ion concentration of 300 mg / L and a fluoride ion concentration of 40 mg / L. Add the calcium fluoride scale inhibitor obtained in Example 1 to a dosage of 15 ppm.

[0034] The scale inhibition performance test showed that the scale inhibition rate of the obtained calcium fluoride reached over 85%.

[0035] Example 4 Prepare a water sample with a calcium ion concentration of 300 mg / L and a fluoride ion concentration of 80 mg / L. Add the calcium fluoride scale inhibitor obtained in Example 1 to a dosage of 20 ppm.

[0036] According to the scale inhibition performance test, the scale inhibition rate of the obtained calcium fluoride is over 70%.

[0037] Comparative Example 1 The difference between this embodiment and Embodiment 2 is that the scale inhibitor added is replaced with commercially available ATMP scale inhibitor. All other steps are the same as in Embodiment 2.

[0038] According to the scale inhibition performance test, the scale inhibition rate of the obtained calcium fluoride is about 70%.

[0039] Comparative Example 2 The difference between this embodiment and Embodiment 3 is that the scale inhibitor is replaced with commercially available ATMP scale inhibitor. All other steps are the same as in Embodiment 3.

[0040] According to the scale inhibition performance test, the scale inhibition rate of the obtained calcium fluoride is about 60%.

[0041] Comparative Example 3 The difference between this embodiment and Embodiment 4 is that the scale inhibitor is replaced with commercially available ATMP scale inhibitor. All other steps are the same as in Embodiment 4.

[0042] The scale inhibition performance test showed that the scale inhibition rate of the obtained calcium fluoride was less than 50%.

[0043] The above embodiments demonstrate that the ATMP / PBTCA / PAMAM compound calcium fluoride scale inhibitor prepared by this invention can significantly inhibit calcium fluoride scaling under different fluoride ion concentrations. When the fluoride ion concentration in the water increases, the good calcium fluoride scale inhibition performance can be maintained by appropriately increasing the dosage of the scale inhibitor.

[0044] The calcium fluoride scale inhibitor described in this invention is particularly suitable for the deep treatment of industrial wastewater containing calcium and fluoride, as well as for scale control in reverse osmosis membrane systems. The dosage of the scale inhibitor can be adjusted according to water quality conditions such as the concentration of calcium ions, fluoride ions, pH value, temperature, and the concentration factor of the membrane system.

[0045] The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention in any way. Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Any person skilled in the art can make some modifications or alterations to the above-disclosed technical content to create equivalent embodiments without departing from the scope of the present invention. Any simple modifications, equivalent substitutions, and improvements made to the above embodiments without departing from the scope of the present invention, based on the technical essence of the present invention and within the spirit and principles of the present invention, shall still fall within the protection scope of the present invention.

Claims

1. A calcium fluoride scale inhibitor, characterized in that, It includes aminotrimethylenephosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, polyamide-amine dendritic macromolecules and aqueous solution, with the following mass percentages: aminotrimethylenephosphonic acid 20%–30%, 2-phosphonobutane-1,2,4-tricarboxylic acid 5%–15%, and polyamide-amine dendritic macromolecules 2%–8%.

2. The calcium fluoride scale inhibitor according to claim 1, characterized in that, Aminotrimethylenephosphonic acid is used to inhibit the formation of calcium fluoride crystals by calcium ions and fluoride ions through complexation and adsorption, and to inhibit the nucleation and growth of calcium fluoride crystals.

3. The calcium fluoride scale inhibitor according to claim 1, characterized in that, 2-Butane phosphonate-1,2,4-tricarboxylic acid is used to reduce the formation and deposition of calcium fluoride crystals by complexing with calcium ions in water and adsorbing onto the surface of calcium fluoride crystals.

4. The calcium fluoride scale inhibitor according to claim 1, characterized in that, Polyamide-amine dendritic macromolecules are used to interact with calcium ions and the surface of calcium fluoride crystals in water through their multifunctional structure, thereby inhibiting the nucleation, growth and aggregation of calcium fluoride crystals.

5. The calcium fluoride scale inhibitor according to claim 1, characterized in that, The aqueous solution is deionized water.

6. A method for preparing the calcium fluoride scale inhibitor according to any one of claims 1 to 5, characterized in that, The specific steps include: Step 1: Weigh out aminotrimethylenephosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, polyamide-amine dendritic macromolecules and aqueous solution according to the predetermined mass percentage; Step 2: Add water to the reaction vessel, and under stirring conditions, add aminotrimethylene phosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid and polyamide-amine dendritic macromolecules in sequence. Step 3: Continue stirring until all components are fully mixed and homogeneous to obtain the calcium fluoride scale inhibitor.

7. The method for preparing a calcium fluoride scale inhibitor according to claim 6, characterized in that, The mixing process in step 3 is carried out at room temperature, and the mixture is stirred until the solution is uniformly transparent or uniformly dispersed.

8. The application of the calcium fluoride scale inhibitor according to any one of claims 1 to 5, characterized in that, The calcium fluoride scale inhibitor is used in the treatment of calcium- and fluoride-containing water to inhibit the formation, nucleation, growth, and deposition of calcium fluoride scale during the water treatment process.